Markets › United States › NYSE › RMD

ResMed Inc

NYSE:RMDHealthcareCBOE:SPESGSTOXX:EDD24BP

$239.72+0.31%At closeAt close · Mon 19 Oct · ≈ AED 880.37 · Market cap $34.58B · Next earnings Thu 29 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	57.5%	56.6%	55.8%	56.7%	59.4%	61.1%	—	—
Operating margin	28.3%	28.0%	26.8%	28.2%	32.7%	33.4%	32.7%	−0.6 pts
Net margin	14.8%	21.8%	21.3%	21.8%	27.2%	26.9%	27.2%	+0.3 pts
EBITDA margin	34.5%	32.9%	32.2%	32.7%	37.2%	36.9%	—	—
Return on equity	16.4%	23.2%	21.7%	21.0%	23.5%	23.1%	23.5%	+0.3 pts
Return on assets	10.0%	15.3%	13.3%	14.9%	17.1%	17.0%	17.1%	+0.1 pts
Return on capital employed	23.7%	22.7%	18.9%	22.1%	23.6%	24.9%	—	—
Debt / equity	0.3×	0.3×	0.4×	0.2×	0.1×	0.1×	0.1×	+135.3%
Debt / assets	16.8%	18.0%	23.4%	12.7%	10.4%	4.5%	—	—
Interest coverage	37.7×	44.8×	23.9×	28.9×	133.7×	0.0×	—	—
Current ratio	1.7×	2.8×	3.1×	2.6×	3.4×	3.1×	3.4×	+11.0%
Quick ratio	1.2×	1.7×	1.8×	1.7×	2.5×	2.4×	—	—
Cash ratio	0.3×	0.4×	0.3×	0.3×	1.2×	1.1×	1.2×	+12.7%
Asset turnover	0.7×	0.7×	0.6×	0.7×	0.6×	0.6×	—	—
Inventory turnover	3.0×	2.1×	1.9×	2.5×	2.3×	2.3×	—	—
Receivables turnover	5.1×	6.2×	6.0×	5.6×	5.2×	5.5×	—	—
Dividend payout	47.8%	31.5%	28.8%	27.7%	22.2%	23.0%	—	—